Navigation Links
Lightwave Logic Addresses the Bio-Medical Diagnostic Market through an Agreement with FiberLogix International Ltd.
Date:8/4/2011

NEWARK, Del., Aug. 4, 2011 /PRNewswire/ -- Lightwave Logic, Inc. (OTC Bulletin Board: LWLG), a technology company focused on the development of a Next Generation Non Linear Optical Polymer Materials Platform for applications in high speed fiber-optic data communications and optical computing, announced today that it has entered into an agreement with FiberLogix International Ltd. of Watford, UK to begin the development and testing of proprietary fiber optic medical diagnostic devices incorporating Lightwave Logic's advanced non-linear optical polymers.

FiberLogix's primary focus is to design all-fiber solutions incorporating their expertise in fiber manufacturing and side polish technologies.  Shafiq Parwaz, Director of Technical Applications for FiberLogix, said, "Our Company has pioneered a new technique to process fiber in such a way as to make a waveguide in the sidewall.  The basic platform has been successfully demonstrated for the sensing and measurement of Hydrogen but the exploitation of our technology combined with Lightwave Logic's polymers has the potential to innovate and mass produce biomedical sensors and create other applications like sensors for infectious agents. These are extremely large markets addressing many billions of dollars of revenue opportunity.  Importantly, this can be accomplished at extremely low cost."

Jim Marcelli, CEO of Lightwave Logic, commented, "We are very pleased to work with FiberLogix.  We believe that the combination of their unique manufacturing skills and our polymer expertise will give birth to a host of high value devices and technologies that can address many different end markets.  This represents a significant potential revenue opportunity for our company in a completely new market for us and further demonstrates the utility of our advanced organic polymer technology platform."


'/>"/>
SOURCE Lightwave Logic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
3. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
4. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
5. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
6. Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
7. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
8. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
9. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 27, 2014 Hovione announced today ... Application with the U.S. Food and Drug Administration (FDA). ... developing improved drug delivery options for established drugs. ... novel formulation using a new patented crystalline base form ... widely prescribed oral antibiotics for acne. Currently, there are ...
(Date:11/26/2014)... Mass. , Nov. 26, 2014   ... AEX: PHIA) today announced expanded availability of its ... DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta[i] , ProGrade ... these solutions now available in the U.S., and ... markets, the portfolio offers Philips, customers innovative solutions ...
(Date:11/26/2014)...  Cohen, Placitella & Roth, PC is investigating ... Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 31, 2011 through November 2, 2014 ("Class Period").  ... its officers and directors publically disseminated materially false ... and 20(a) of the Securities Exchange Act of ...
Breaking Medicine Technology:Hovione Files its First Investigational New Drug Application With the FDA 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
(Date:11/28/2014)... The report “Poxvirus Infections Pipeline Review ... development for Poxvirus Infections, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Poxvirus Infections and special features on late-stage and ...
(Date:11/28/2014)... Recently, SWAccessControl.com, a renowned smartware manufacturer, has announced ... these high end products are offered at discounted rates, ... last from today to Dec 16, 2014. , The ... the promotion. We are proud of our new access ... information about our hottest items, we have listed some ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... physical therapy techniques such as Dynamic Neuromuscular Stabilization, ... and gait/motion analysis. After moving to upgraded facilities ... and running clinic. Now, owner Dr. Lev Kalika ... performance and injury prevention lab in the country. ...
(Date:11/28/2014)... 28, 2014 (HealthDay News) -- People with diabetes face a ... help keep you healthy, an expert says. "With the ... deal with the events, the family you,ll be visiting and ... Association of Diabetes Educators, said in an association news release. ... be healthy." One idea is to make a healthy ...
(Date:11/28/2014)... Sunnyvale, CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was ... their communities by giving to local charities and causes. ... Thanksgiving Holiday, coincides with the kickoff of the holiday ... Friday is to shopping and Cyber Monday is to ...
Breaking Medicine News(10 mins):Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3Health News:Holiday Eating Tips for People With Diabetes 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3
... 18, 2011 HIV-positive head and neck cancer patients ... toxicity rates as non-HIV-positive patients, despite prior reports to ... issue of the International Journal of Radiation OncologyBiologyPhysics ... Radiation Oncology (ASTRO). , Patients with HIV have a ...
... A new program designed to create comprehensive, integrated, whole-person ... a $3.9 million grant from the Colorado Health Foundation. ... in the Department of Family Medicine at the University of ... and national leaders from the mental health, substance use, and ...
... (HealthDay News) -- Seeing a character in a movie light ... motions, new research shows. In the study, functional MRI ... 17 nonsmokers as they watched movie scenes that featured smoking. ... activity in areas involved in movement of the hand they ...
... more likely to have seriously considered suicide than their peers ... Toronto , In a paper published online this week in ... differences among a sample of 6,647 adults, of whom 695 ... study found that men from divorced families had more than ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... from patients suggest that a controversial treatment for multiple ... many physicians remain highly skeptical of the claims. ... Zamboni, a vascular surgeon from Italy, published an intriguing ...
... of Technology indicates that the incidence of maltreatment, including ... 25 percent higher among deaf and hard-of-hearing children than ... correlation between childhood maltreatment and higher rates of negative ... study, which was presented at the 2010 annual meeting ...
Cached Medicine News:Health News:HIV-positive head and neck cancer patients benefit from radiation therapy 2Health News:New program targeting whole-person health care gets major grant 2Health News:Smoking Scenes in Movies Light Up Smokers' Brains 2Health News:Parental divorce linked to suicidal thoughts 2Health News:Vein-Opening Treatment for MS Stirs Controversy 2Health News:Vein-Opening Treatment for MS Stirs Controversy 3Health News:Vein-Opening Treatment for MS Stirs Controversy 4Health News:Study: Abuse rates higher among deaf and hard-of-hearing children compared with hearing youths 2
... , ... event is to use an ... environment. But will the device be durable enough? Can you depend, ... its signal quality? Will the battery last? Is it comfortable, ...
... new features and state-of-the ... innovation, the SuperStim brain ... stimulation up to 30 ... and transcranial stimulation up ...
... high-volume analyzer that builds upon the field-proven ... and the latest Olympus technological advances. The ... with up to 147 on-board chemistries and ... Choose from Olympus 122 test menu, including ...
... The AU640 e is ... mid-sized to large laboratories and hospitals. ... the AU640es field-proven reliability and Olympus ... chemistries, urine chemistry, specific proteins, esoteric ...
Medicine Products: